RIGL vs. SII
RIGL (Rigel Pharmaceuticals, Inc.) and SII (Sprott Inc) are both stocks. RIGL operates in Biotechnology (Healthcare), while SII operates in Asset Management (Financial Services). Over the past 5 years, RIGL returned -3.96%/yr vs 25.04%/yr for SII. At a 0.16 correlation, their price movements are largely independent.
Performance
RIGL vs. SII - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RIGL achieves a -23.30% return, which is significantly lower than SII's 22.00% return.
RIGL
- 1D
- 2.40%
- 1M
- 2.24%
- YTD
- -23.30%
- 6M
- -19.45%
- 1Y
- 54.23%
- 3Y*
- 27.10%
- 5Y*
- -3.96%
- 10Y*
- 3.28%
SII
- 1D
- 2.63%
- 1M
- -16.47%
- YTD
- 22.00%
- 6M
- 27.36%
- 1Y
- 90.24%
- 3Y*
- 56.34%
- 5Y*
- 25.04%
- 10Y*
- —
RIGL vs. SII - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
RIGL Rigel Pharmaceuticals, Inc. | -23.30% | 154.64% | 16.00% | -3.33% | -43.40% | -24.29% | 90.22% |
SII Sprott Inc | 22.00% | 137.17% | 27.39% | 5.00% | -24.09% | 59.43% | -19.45% |
Correlation
The correlation between RIGL and SII is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Jun 29, 2020 | 0.16 |
The correlation between RIGL and SII shifts across timeframes, from 0.05 (1 year) to 0.17 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
RIGL:
$646.69M
SII:
$2.20B
RIGL:
$19.21
SII:
$3.53
RIGL:
1.71
SII:
33.69
RIGL:
0.00
SII:
0.90
RIGL:
2.08
SII:
7.55
RIGL:
1.62
SII:
5.78
RIGL:
$299.77M
SII:
$377.77M
RIGL:
$279.95M
SII:
$278.09M
RIGL:
$125.80M
SII:
$120.39M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RIGL vs. SII — Risk / Return Rank
RIGL
SII
RIGL vs. SII - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rigel Pharmaceuticals, Inc. (RIGL) and Sprott Inc (SII). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RIGL | SII | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.16 | ||
| Sortino ratioReturn per unit of downside risk | -0.91 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.33 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | 1.09 | 2.84 | -1.75 |
| Martin ratioReturn relative to average drawdown | 1.91 | 7.83 | -5.92 |
Loading charts...
Drawdowns
RIGL vs. SII - Drawdown Comparison
The maximum RIGL drawdown since its inception was -99.37%, which is greater than SII's maximum drawdown of -47.81%. Use the drawdown chart below to compare losses from any high point for RIGL and SII.
Loading charts...
Drawdown Indicators
| RIGL | SII | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.37% | -47.81% | -51.56% |
Max Drawdown (1Y)Largest decline over 1 year | -50.08% | -32.00% | -18.08% |
Max Drawdown (3Y)Largest decline over 3 years | -57.75% | -32.00% | -25.75% |
Max Drawdown (5Y)Largest decline over 5 years | -85.24% | -47.81% | -37.43% |
Max Drawdown (10Y)Largest decline over 10 years | -86.40% | — | — |
Current DrawdownCurrent decline from peak | -96.93% | -28.38% | -68.55% |
Average DrawdownAverage peak-to-trough decline | -90.91% | -21.08% | -69.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.64% | 11.57% | +17.07% |
Volatility
RIGL vs. SII - Volatility Comparison
The current volatility for Rigel Pharmaceuticals, Inc. (RIGL) is 12.05%, while Sprott Inc (SII) has a volatility of 12.83%. This indicates that RIGL experiences smaller price fluctuations and is considered to be less risky than SII based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RIGL | SII | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.05% | 12.83% | -0.78% |
Volatility (6M)Calculated over the trailing 6-month period | 36.64% | 40.12% | -3.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 69.89% | 46.77% | +23.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 85.46% | 37.64% | +47.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 82.81% | 37.67% | +45.14% |
Dividends
RIGL vs. SII - Dividend Comparison
RIGL has not paid dividends to shareholders, while SII's dividend yield for the trailing twelve months is around 1.26%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
RIGL Rigel Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SII Sprott Inc | 1.26% | 1.33% | 2.49% | 2.95% | 3.00% | 2.22% | 1.66% |
Financials
RIGL vs. SII - Financials Comparison
This section allows you to compare key financial metrics between Rigel Pharmaceuticals, Inc. and Sprott Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RIGL vs. SII - Profitability Comparison
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
SII - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sprott Inc reported a gross profit of 131.24M and revenue of 143.35M. Therefore, the gross margin over that period was 91.6%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
SII - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sprott Inc reported an operating income of 41.26M and revenue of 143.35M, resulting in an operating margin of 28.8%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
SII - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sprott Inc reported a net income of 28.81M and revenue of 143.35M, resulting in a net margin of 20.1%.
Frequently Asked Questions
RIGL and SII have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SII has higher volatility (12.83%) compared to RIGL (12.05%). In terms of maximum drawdown, RIGL dropped -99.37% vs SII's -47.81%.
SII currently has the higher Sharpe Ratio (1.94 vs 0.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RIGL and SII
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer